Scientists begin melting Earth's oldest ice to unlock 1,500,000-year-old secrets
Unassuming, icicle-like tubes could help answer mysteries about Earth's climate.
They are the world's oldest ice cores, which have just landed in the UK after being drilled from the depths of Antarctica.
While most of Britain is reeling from weeks of back-to-back heatwaves, scientists in Cambridge find out what the rare blocks of ice can reveal about climate change and our home planet.
But to get hold of the ice, they first had to drill for 1.7 miles down the ice sheet at the South Pole.
The giant stick of ice was then cut into more manageable chunks and transported to Europe.
Scientists hope the pieces will reveal why the planet's climate cycle shifted more than a million years ago, helping to predict Earth's future response to rising greenhouse gas.
Dr Liz Thomas, from the British Antarctic Survey in Cambridge, told Reuters: 'We really are exploring a completely unknown time in our history.
'We are hoping to unlock all these amazing secrets.'
The new core ice, which was drilled near the Concordia research station in the 'White Continent,' beats the previous 800,000-year-old ice, which was drilled in the early 2000s.
Until now, scientists have relied on marine sediments to study the climate cycles. over millions of years.
But ice has a special feature invisible to the naked eye – entrapped bubbles showing the atmospheric conditions, amount of greenhouse gas in the air and chemical evidence of temperatures at the time when they were released.
And to not make the job too easy for the scientists, Antarctica is the only place on Earth where such a long record of the atmosphere is found.
Summer temperatures at the French-Italian Concordia station range from -30°C to -50°C, and can reach a brain-numbing -80°C in winter.
Dr Thomas continued: 'Our data will yield the first continuous reconstructions of key environmental indicators—including atmospheric temperatures, wind patterns, sea ice extent, and marine productivity—spanning the past 1.5 million years.
'This unprecedented ice core dataset will provide vital insights into the link between atmospheric CO₂ levels and climate during a previously uncharted period in Earth's history, offering valuable context for predicting future climate change.'
The world's largest ice sheet remains shrouded in mystery and intrigue as relatively little is still known about Antarctica. More Trending
Geologists believe the continent was once covered in rivers and forests.
Satellite data and radars revealed ridges and valleys, suggesting the icy no man's land looked very different 34 million years ago.
Meanwhile, conspiracy theorists have their eyes set on Antarctica after Google Map sleuths believe they have found a secret door buried in the mountainside.
Get in touch with our news team by emailing us at webnews@metro.co.uk.
For more stories like this, check our news page.
MORE: Scorching 40°C temperatures 'will soon become the new normal for the UK'
MORE: I love living in London — but it's absolutely vile in the summer
MORE: Blame, thoughts and prayers – the uncomfortable truth about politicians and natural disasters
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
3 hours ago
- Daily Mail
Contraception used by thousands increases risk of brain tumour, study finds
Women on a widely–used contraceptive jab are three–and–a–half times more likely to suffer a potentially–fatal brain tumour, a study shows. It's the third major investigation in just over a year to show the jab raises the risk of a meningioma, the most common type of tumour in the brain, in those on it for 12 months or more. Around 10,000 prescriptions a month are issued for medroxyprogesterone acetate— sold under the brand name Depo Provera—in England alone. Hundreds of women in the UK are now reported to be considering legal action against the manufacturer Pfizer, for not warning them of the risks. A class action is already underway against Pfizer and other generic manufacturers of the jab in the US, where more than 500 women allege the companies were aware of the link but failed to adequately warn users of the risks or promote safer alternatives. The drug is a hormone injection give every three months and works by preventing eggs from being released by a woman's ovaries. It was first licensed for use on the NHS as a contraceptive over 40 years ago. But a 2024 study in the British Medical Journal of more than 18,000 women, by a team of scientists from the French National Agency for Medicines and Health Products Safety, concluded those who stayed on it for at least a year were up to five times more at risk of a meningioma. The jab is administered every three months in a doctor's surgery or sexual health clinic A second probe in September last year, by researchers at the University of Alabama in the US, produced similar results. Although non–cancerous, the condition can cause blurred vision, headaches, hearing loss, poor sense of smell and problems with swallowing. Tumours are normally slow–growing but can kill by compressing the brain and nerves if they grow too big. Between 2,000 and 3,000 people a year in the UK are diagnosed with a meningioma and it's more common in women. In the latest study, scientists at the University of British Columbia in Vancouver, Canada, compared meningioma rates in 72,181 women on the jab with more than 247,000 women on oral contraception. The results, in the journal Expert Opinion on Drug Safety, showed the risks were more than trebled in long–term users of the jab. Researcher Dr Mahyar Etminan said the dangers did not appear to increase the more years women spent on the drug. But he added: 'I do believe the evidence is now robust, with three large studies showing pretty much the same thing. 'Women concerned about this risk may want to consider opting for alternative contraceptives.' It's not clear why the jab triggers tumour growth. One theory is the synthetic hormone it uses – progestogen – binds to meningioma cells and helps them grow. Some research suggests certain versions of the Pill made with progestogen can also heighten the risk of meningioma but only in a small proportion of women who take it for more than five years. The UK drug safety watchdog—the Medicines and Healthcare Products Regulatory Agency—last October called on Pfizer to include a warning about the heightened risk in patient information leaflets. Pfizer also wrote to NHS doctors urging them to immediately stop women from using Depo Provera if they were diagnosed with a meningioma. Virginia Buchanan, partner at Levin Papantonio—the law firm handling the case in the US—said: 'This new study reinforces the need for legal action against Pfizer, with the hope of bringing justice for the women who have never been warned about the increased risk of developing a brain tumour from using Depo–Provera and who have gone on to develop meningiomas.'
Daily Mail
4 hours ago
- Daily Mail
France names space rocket Orbital BAGUETTE One... can you spot the clever nod to Star Wars?
France has officially entered the space race with a rocket named Orbital Baguette One - and the name quietly nods to Star Wars. The country known for wine, cheese and existential cinema is now hoping to take over the cosmos with a crusty carb-themed spacecraft. The name is not just riffing on France's iconic bread - its OB-1 abbreviation also pays a playful tribute to Jedi Master Obi-Wan Kenobi. While rockets steeped in fantasy, such as Pegasus, Antares, and Atlas V, have dominated the space race, the French have decided to take a more boulangerie chic approach when choosing a name. Backed by President Emmanuel Macron and developed by a start-up called HyPrSpace, Baguette One is a small, reusable suborbital launcher that promises cheap and eco-friendly satellite transport. A test flight is scheduled from a French military base, with a bigger version, Orbital Baguette One, to follow. Co-founder Sylvain Bataillard said the company wanted to be 'serious but not sinister' when picking the name. The rocket uses what HyPrSpace calls 'revolutioary hybrid propulsion,' powered by a mix of liquid and solid propellants, some made from recycled plastic. There are no turbo-pumps, and the chamber is pressurised with helium, which the company says helps keep costs low. Despite the playful branding, the project has serious backing. France's government has already handed over $41million, with another $470million up for grabs if initial launches succeed. The defense ministry is giving up military bases in southwest France and Provence for testing, making this the first rocket launch from mainland France. According to The Times, TV presenters on TF1 had a hard time trying to keep a straight face when reporting on the project this week, especially after showing an AI image of a baguette on a launchpad. But with global demand for satellite launches booming, no one is laughing at the potential. The Novaspace consultancy predicts more than 26,000 satellites will be launched by 2032. HyPrSpace wants to corner a slice of that market with its microlauncher, which it describes as a satellite 'taxi' offering flexible lift-off dates at half the usual cost. Most small rockets charge $47,000 per kilogram. Baguette One aims to do it for around $23,000. While SpaceX continues to dominate and Europe lags behind, France is hoping its crusty challenger will rise to the occasion. OB-1 may sound like a bakery joke, but Macron's government is betting it could be the future of French space travel.
Reuters
5 hours ago
- Reuters
China issues ethical guidelines for autonomous driving technology
BEIJING, July 23 (Reuters) - China's science and technology ministry on Wednesday issued ethical guidelines for autonomous driving technology, requiring developers to prioritise user safety and refrain from spreading false information when publishing research results. Algorithms and models related to autonomous driving technology should be recorded and made accessible while data collection in the development and application of the technology should be limited to the scope required to achieve driving functions, the guidelines say. The guidelines also specify which party - the human driver or the driving system - is liable when driving with such systems, based on how advanced the system is.
